デフォルト表紙
市場調査レポート
商品コード
1663092

動物用POC診断薬市場規模、シェア、成長分析:製品別、動物タイプ別、サンプルタイプ別、適応症別、検査別、最終用途別、地域別 - 産業予測 2025~2032年

Veterinary POC Diagnostics Market Size, Share, and Growth Analysis, By Product, By Animal Type, By Sample Type, By Indication, By Testing, By End Use, By Region - Industry Forecast 2025-2032


出版日
発行
SkyQuest
ページ情報
英文 219 Pages
納期
3~5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=145.94円
動物用POC診断薬市場規模、シェア、成長分析:製品別、動物タイプ別、サンプルタイプ別、適応症別、検査別、最終用途別、地域別 - 産業予測 2025~2032年
出版日: 2025年02月19日
発行: SkyQuest
ページ情報: 英文 219 Pages
納期: 3~5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

動物用POC診断薬の世界市場規模は、2023年に25億米ドルと評価され、予測期間(2025-2032年)にCAGR 12.1%で成長し、2024年の28億米ドルから2032年には69億9,000万米ドルに成長する見通しです。

獣医市場は動物の健康維持に重要な役割を果たしており、獣医師は病気や怪我に対処し、様々な種について重要な調査を行っています。獣医師は、歯科治療、手術、予防接種を行い、コンパニオンアニマルや家畜動物の健康を確保しています。ポイントオブケア(POC)診断の出現は、中央検査室に依存することなく臨床に関連したデータを提供し、診療現場で個々の開業医に力を与えるため、大きな利点をもたらします。これは、食料、労働力、社会的地位を家畜や家禽に依存する農村部の人々にとって特に重要です。しかし、このような依存には、人獣共通感染症のリスクなどの課題が付きまとい、動物と公衆衛生の両方を効果的に守るための積極的な獣医療の必要性が浮き彫りになります。

目次

イントロダクション

  • 調査の目的
  • 調査範囲
  • 定義

調査手法

  • 情報調達
  • 二次と一次データの方法
  • 市場規模予測
  • 市場の前提条件と制限

エグゼクティブサマリー

  • 世界市場の見通し
  • 供給と需要の動向分析
  • セグメント別機会分析

市場力学と見通し

  • 市場概要
  • 市場規模
  • 市場力学
    • 促進要因と機会
    • 抑制要因と課題
  • ポーターの分析

主な市場の考察

  • 重要成功要因
  • 競合の程度
  • 主な投資機会
  • 市場エコシステム
  • 市場の魅力指数(2024年)
  • PESTEL分析
  • マクロ経済指標
  • バリューチェーン分析
  • 価格分析

動物用POC診断薬市場規模:製品別& CAGR(2025-2032)

  • 市場概要
  • 消耗品試薬キット
  • 機器とデバイス

動物用POC診断薬市場規模:動物タイプ別& CAGR(2025-2032)

  • 市場概要
  • コンパニオンアニマル
    • その他
  • 家畜
    • 家禽

動物用POC診断薬市場規模:サンプルタイプ別& CAGR(2025-2032)

  • 市場概要
  • 血液/血漿/血清
  • 尿
  • 糞便
  • その他

動物用POC診断薬市場規模:適応症別& CAGR(2025-2032)

  • 市場概要
  • 感染症
  • 一般的な病気
  • その他

動物用POC診断薬市場規模:検査別& CAGR(2025-2032)

  • 市場概要
  • 血液学
  • 診断画像
  • 細菌学
  • ウイルス学
  • 細胞学
  • 臨床化学
  • 寄生虫学
  • 血清学
  • その他

動物用POC診断薬市場規模:最終用途別& CAGR(2025-2032)

  • 市場概要
  • 動物病院・クリニック
  • ホームケア設定
  • その他

動物用POC診断薬市場規模:地域別& CAGR(2025-2032)

  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • スペイン
    • フランス
    • 英国
    • イタリア
    • その他欧州地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • その他ラテンアメリカ地域
  • 中東・アフリカ
    • GCC諸国
    • 南アフリカ
    • その他中東・アフリカ

競合情報

  • 上位5社の比較
  • 主要企業の市場ポジショニング(2024年)
  • 主な市場企業が採用した戦略
  • 最近の市場動向
  • 企業の市場シェア分析(2024年)
  • 主要企業の企業プロファイル
    • 企業の詳細
    • 製品ポートフォリオ分析
    • 企業のセグメント別シェア分析
    • 収益の前年比比較(2022-2024)

主要企業プロファイル

  • IDEXX Laboratories, Inc.(USA)
  • Zoetis(USA)
  • Heska Corporation(USA)
  • Virbac(France)
  • Merck Animal Health(USA)
  • Antech Diagnostics(USA)
  • Mindray Medical(China)
  • BioRad Laboratories(USA)
  • Seegene(South Korea)
  • Abbott Laboratories(USA)
  • Beckman Coulter(USA)
  • Randox Laboratories(UK)
  • Siemens Healthineers(Germany)
  • DiaSorin(Italy)
  • BioMerieux(France)
  • Thermo Fisher Scientific(USA)
  • Roche Diagnostics(Switzerland)
  • Quidel(USA)

結論と提言

目次
Product Code: SQMIG35A2190

Global Veterinary POC Diagnostics Market size was valued at USD 2.5 billion in 2023 and is poised to grow from USD 2.8 billion in 2024 to USD 6.99 billion by 2032, growing at a CAGR of 12.1% during the forecast period (2025-2032).

The veterinary market plays a vital role in maintaining animal health, with veterinarians addressing illnesses, injuries, and conducting crucial research on various species. They perform dental work, surgeries, and provide vaccinations, ensuring the well-being of companion and livestock animals alike. The emergence of point-of-care diagnostics offers significant advantages, as these streamlined tests deliver clinically relevant data without relying on central laboratories, empowering individual practitioners at the site of care. This is particularly important for rural populations who depend on livestock and poultry for food, labor, and social standing. However, this reliance comes with challenges, such as the risk of zoonotic infections, highlighting the need for proactive veterinary care to safeguard both animal and public health effectively.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Veterinary Poc Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Veterinary PoC Diagnostics Market Segments Analysis

Global Veterinary POC Diagnostics Market is segmented by Product, Animal Type, Sample Type, Indication, Testing, End Use and region. Based on Product, the market is segmented into Consumables, Reagents, & Kits and Instruments & Devices. Based on Animal Type, the market is segmented into Companion Animals and Livestock Animals. Based on Sample Type, the market is segmented into Blood/Plasma/Serum, Urine, Fecal and Others. Based on Indication, the market is segmented into Infectious Disease, General Ailments and Others. Based on Testing, the market is segmented into Hematology, Diagnostic Imaging, Bacteriology, Virology, Cytology, Clinical Chemistry, Parasitology, Serology and Others. Based on End Use, the market is segmented into Veterinary Hospitals & Clinics, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Veterinary PoC Diagnostics Market

The global veterinary point-of-care (PoC) diagnostics market is expected to witness significant growth in the coming years, driven by the rising demand for PoC test kits. However, this growth may be tempered by limitations in reimbursement policies. On the positive side, factors such as the increasing prevalence of pandemic-related diseases, the demand for quicker diagnostic results, enhanced accuracy in testing, evolving diagnostic trends, and the integration of advanced technologies are anticipated to contribute to the expansion of the veterinary PoC diagnostics market throughout the forecast period. This dynamic landscape holds promise for growth despite the existing challenges.

Restraints in the Global Veterinary PoC Diagnostics Market

The Global Veterinary Point-of-Care (POC) Diagnostics market faces a significant challenge due to the high costs associated with contemporary diagnostic tests and imaging systems. Small portable diagnostic machines range from USD 2,000 to USD 50,000, while ancillary equipment, such as backup transducer probes and printers, can add to the expense, with prices reaching up to USD 1,000 and USD 2,000, respectively. Most veterinary practices are small to medium-sized and often operate under strict financial constraints, making the affordability of these advanced systems a critical concern. Additionally, limited reimbursement options for veterinary services further restrict the widespread adoption of diagnostic technologies, hindering market growth.

Market Trends of the Global Veterinary PoC Diagnostics Market

The Global Veterinary Point of Care (PoC) Diagnostics market is experiencing significant growth driven by increasing awareness of zoonotic diseases, which account for a substantial portion of human illnesses. The CDC has highlighted the urgency for enhanced animal health monitoring, particularly in livestock, to mitigate the risks associated with these diseases. As a response, there is a growing demand for advanced diagnostic technologies that facilitate rapid disease identification and tracking. Innovations, research, and educational initiatives are empowering veterinarians to improve diagnostic accuracy and treatment efficacy, further stimulating demand. Consequently, the market is poised for expansion as stakeholders seek to solidify their competitive edge in this crucial sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis

Global Veterinary POC Diagnostics Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Consumables, Reagents, & Kits
  • Instruments & Devices

Global Veterinary POC Diagnostics Market Size by Animal Type & CAGR (2025-2032)

  • Market Overview
  • Companion Animals
    • Dogs
    • Cats
    • Horses
    • Others
  • Livestock Animals
    • Cattle
    • Swine
    • Poultry

Global Veterinary POC Diagnostics Market Size by Sample Type & CAGR (2025-2032)

  • Market Overview
  • Blood/Plasma/Serum
  • Urine
  • Fecal
  • Others

Global Veterinary POC Diagnostics Market Size by Indication & CAGR (2025-2032)

  • Market Overview
  • Infectious Disease
  • General Ailments
  • Others

Global Veterinary POC Diagnostics Market Size by Testing & CAGR (2025-2032)

  • Market Overview
  • Hematology
  • Diagnostic Imaging
  • Bacteriology
  • Virology
  • Cytology
  • Clinical Chemistry
  • Parasitology
  • Serology
  • Others

Global Veterinary POC Diagnostics Market Size by End Use & CAGR (2025-2032)

  • Market Overview
  • Veterinary Hospitals & Clinics
  • Home Care Settings
  • Others

Global Veterinary POC Diagnostics Market Size & CAGR (2025-2032)

  • North America (Product, Animal Type, Sample Type, Indication, Testing, End Use)
    • US
    • Canada
  • Europe (Product, Animal Type, Sample Type, Indication, Testing, End Use)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product, Animal Type, Sample Type, Indication, Testing, End Use)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product, Animal Type, Sample Type, Indication, Testing, End Use)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product, Animal Type, Sample Type, Indication, Testing, End Use)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • IDEXX Laboratories, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Zoetis (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Heska Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virbac (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck Animal Health (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Antech Diagnostics (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mindray Medical (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioRad Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Seegene (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Beckman Coulter (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Randox Laboratories (UK)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthineers (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • DiaSorin (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioMerieux (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Roche Diagnostics (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Quidel (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations